FAQs

What is Evofem’s ticker symbol?

EVFM

What exchange is Evofem stock traded on?

Our publicly available stock is traded on the NASDAQ Capital Market.

How can I invest in Evofem?

You must contact a registered broker to invest in Evofem (EVFM) stock.

What is the CUSIP number for Evofem?

30048L 104 

How did Evofem become a public company?

Evofem became a public company through a reverse merger with Neothetics, Inc., which closed January 17, 2018.

What year was Evofem incorporated?

Evofem, Inc. was incorporated in 2009. However, Evofem, Inc.'s ultimate parent company Evofem Biosciences, Inc. was incorporated in 2015

Where is Evofem headquartered?

Evofem headquarters are in San Diego, CA.

How many shares of Evofem are outstanding?

Please refer to the SEC filings webpage of the Investor section of our website.

Who is Evofem’s transfer agent for ordinary shares?

Philadelphia Stock Transfer
Bob Winterle
Tel: 484-416-3124
Email: bwinterle@philadelphiastocktransfer.com

I hold common warrants that were issued in May 2018 and expire May 2025. How do I exercise these warrants?

For the May 2018 warrants, you may exercise warrants directly through Philadelphia Stock Transfer by submitting a Deposit/Withdrawal by Custodian (DWAC) withdrawal on the warrants and a DWAC deposit on the common once exercise funds were confirmed and received. 
 

For more information, please contact:

Philadelphia Stock Transfer
Bob Winterle
Tel: 484-416-3124
Email: bwinterle@philadelphiastocktransfer.com

What is the exercise price of the May 2018 common warrants?

Each common warrant issued in May 2018 entitles the holder to purchase one fifth of a share of Evofem Biosciences’ common stock at an exercise price of $7.50 per share.

How can I get Evofem’s financial documents?

Please refer to the SEC filings webpage of the Investor section of our website. 

Who are Evofem’s independent auditors?

Deloitte LLP

Who is Evofem’s corporate counsel?

Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. 

What does Evofem do?

Evofem Biosciences develops and anticipates commercializing innovative products to address unmet needs in women's sexual and reproductive health.

When will earnings be announced?

Plans for reporting of Evofem's quarterly and annual financial results will be announced in advance; please check the Events and Presesntations section within the Investor section of our website for details, or sign up for news alerts to be notified by email.

When is the stockholder meeting held?

The dates for stockholder meetings are determined by the Board of Directors and will be disclosed in our proxy filings with the SEC, which are available through the SEC Filings tab of the Investors section of our website (click here).

Are you on a calendar or fiscal year?

Evofem is on a calendar year that ends December 31.

How can I access Evofem’s earnings webcast?

In the event quarterly and/or annual financial results calls or webcasts are scheduled, access information will be disclosed in a press release and included in the Events and Presentations section within the Investor relations section of our website.

How can I contact Evofem’s investor relations department?

Please contact Amy Raskopf at araskopf@evofem.com or 858.550.1900 x 167.

How can I get added to Evofem’s mailing list?

You can sign up for e-mail alerts notifying you of new press releases, SEC filings or corporate actions and events on the “Investor Contacts and Alerts” page of the Investor section of our website.